FDA Overreach Concerns
A group of physicians is challenging the FDA's authority after the agency launched a campaign against the use of ivermectin for COVID-19. They argue that the FDA has overstepped its boundaries, causing reputational harm and professional consequences for them. The physicians emphasize the importance of individualized patient care and the common practice of using off-label medications, seeking to set a precedent to prevent future overreach by the FDA.In this clip
From this podcast
Doc Malik
Conversation With BreatheMD, Dr Mary Bowden
Related Questions